Concepedia
Statistics
Publications
48
Citations
2.6K
H-Index
27
Active since
1975
Affiliations
University of Hertfordshire(Current)
New Frontier
Molecular Discovery (United Kingdom)
Smiths Detection (Canada)
Michael E. Parsons is an author at University of Hertfordshire specializing in medicine, pharmacology, and drug discovery.
Top concepts
MedicinePharmacologyPhysiologyDrug DiscoveryPharmacotherapyMolecular PharmacologyBiochemistryGastroenterologyMedicinal ChemistryNatural Sciences
Publications per year
1975–2017
Cimetidine—A Non-Thiourea H<sub>2</sub>-Receptor Antagonist
R.W. Brimblecombe, W. A. M. Duncan, G. J. DURANT et al. · Journal of International Medical Research · 1975 · 450 citations
Molecular Pharmacology, Pharmacological Study, Medicine +7
Chemical differentiation of histamine H1- and H2-receptor agonists
Graham J. Durant, C. Robin Ganellin, Michael E. Parsons · Journal of Medicinal Chemistry · 1975 · 260 citations
Medicinal Chemistry, Allergy, Biochemistry +12
Dimaprit-[S-[3-(N,N-dimethylamino)propyl]isothiourea] —A highly specific histamine H2-receptor agonist. Part 1. Pharmacology
Michael E. Parsons, D. A. A. Owen, C. Robin Ganellin et al. · Inflammation Research · 1977 · 241 citations
Molecular Pharmacology, Allergy, Medicine +5
Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors
G. J. DURANT, W. A. M. Duncan, C. Robin Ganellin et al. · Nature · 1978 · 222 citations
Allergy, Functional Selectivity, Specific Agonist +8
An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease
Akilah Sykes, Christopher Brampton, Sabine Klee et al. · Inflammation Research · 2000 · 75 citations
Inflammation, Tobacco Control, Functional Gastrointestinal Disorder +6
1–5 of 48